A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets

PURPOSE: Despite new treatments, acute myeloid leukemia (AML) remains an incurable disease. More effective drug design requires an expanded view of the molecular complexity that underlies AML. Alternative splicing of RNA is used by normal cells to generate protein diversity. Growing evidence indicat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cancer Res
Päätekijät: Adamia, Sophia, Haibe-Kains, Benjamin, Pilarski, Patrick M., Bar-Natan, Michal, Pevzner, Samuel, Avet-Loiseau, Herve, Lode, Laurence, Verselis, Sigitas, Fox, Edward A., Burke, John, Galinsky, Ilene, Dagogo-Jack, Ibiayi, Wadleigh, Martha, Steensma, David P., Motyckova, Gabriela, Deangelo, Daniel J., Quackenbush, John, Stone, Richard, Griffin, James D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4458245/
https://ncbi.nlm.nih.gov/pubmed/24284058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0956
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia